心复康口服液对心梗后心衰大鼠模型心功能及心肌能量代谢干预的研究
|
摘要
目的:观察心复康口服液对心梗后心衰大鼠血流动力学、心功能及心肌能量代谢物质的影响。
方法:采用结扎SD大鼠左冠状动脉前降支致心梗后心衰大鼠模型,大鼠随机分为假手术组(Sham组)、模型组(Model组)、Captopril组(Capt组)、益气活血中药组分为心复康口服液大剂量组(XFK大剂量组)和心复康口服液小剂量组(XFK小剂量组),分别于术后24h灌胃给药,以Captopril作为阳性对照药。给药8周末,观察大鼠血流动力学、心功能及心肌能量代谢物质的的变化。
结果:
(1)XFK对心梗后CHF大鼠血流动力学的影响
与Sham组比较,Model组大鼠舒张压降低,统计学有显著性差异(P<0.05),心率及收缩压变化无统计学意义(P>0.05);与Model组比较,XFK组和Capt组大鼠心率及舒张压变化均无统计学意义,但Capt组大鼠收缩压明显降低,统计学有极显著性差异(P<0.01)。
(2)XFK对心梗后CHF大鼠心功能的影响
与Sham组比较,Model组大鼠左心室舒张末压升高,左心室收缩压、心输出量、左心室内压最大上升速率、左心室内压最大下降速率均显著降低,统计学有极显著性差异(P<0.01);与Model组比较,XFK组和Capt组大鼠左心室舒张末压降低,统计学有显著性差异(P<0.05),左心室收缩压、心输出量、左心室内压最大上升速率、左心室内压最大下降速率均升高,统计学有极显著性差异(P<0.01)。
(3)XFK对CHF大鼠左心室非梗死心肌ATP、AMP、ADP水平的影响
与Sham组比较,Model组大鼠左心室心肌ATP含量降低,ADP、AMP含量明显增高,统计学有极显著性意义(P<0.01);与Model组比较,XFK组和Capt组大鼠左心室心肌ATP水平明显升高,ADP和AMP含量明显降低,统计学有极显著性意义(P<0.01)。
结论:
(1)心复康口服液对心梗后心衰大鼠心率、BSP、BDP无影响,可有效降低心梗后心衰大鼠心脏LVEDP,提高心梗后心衰大鼠LVSP,改善心梗大鼠血液动力学稳态。
(2)心复康口服液可有效提高心梗后心衰大鼠心脏+dp/dtmax、CO,从而改善心梗后心衰大鼠左室收缩和舒张功能。
(3)心复康口服液可有效提高心梗后心衰大鼠心肌能量代谢产物ATP含量,减少AMP、ADP的含量。说明益气活血中药可有效调节心梗后心衰大鼠心肌能量代谢紊乱,改善心梗后心衰大鼠心肌能量代谢重塑,从而保护心功能。
Objetives: To observe the effect of Xinfukang(XFK)oral liquid on hemodynamics、cardiac function and the content of energy metabolism material in the rat model of Heart Failure post Myocardial Infarction.
Methods: The AMI models were established by ligating left anterion descending coronary artery and the rats with AMI were ramdonly divided into Sham group、Model group、Captopril group ,Yiqihuoxue chinese medicine into XFK high dose group and XFK low dose group.Twenty-four hours after establishing models the rats were fed on XFK oral liquid through the gastrotube for 8weeks. Captopril group was serrved as control,After 8 weeks of the treatment,Hemodynamics、cardiac function and the content of energy metabolism material were measured.
Results:
(1) The effect of Xinfukang(XFK)oral liquid on hemodynamics of Heart Failure post Myocardial Infarction in rats Contrast with sham group, diastolic blood pressure in model rats was lowered, with statistically significant difference (P<0.05),heart rate and blood pressure change were not significant (P>0.05);compared with model group, heart rate and diastolic blood pressure changes were not statistically significant both in XFK group and Captopril group,but systolic blood pressure in Captopril group was decreased significantly,with statistically very significant difference (P <0.01)。
(2) the effect of Xinfukang(XFK)oral liquid on cardiac function of Heart Failure post Myocardial Infarction in rats Contrast with sham group,left end-diastolic pressure(LVEDP) was obviously increased , left ventricular systolic pressure(LVSP)、cardiac output(CO),as well as maximum rate of rise and fall of left systolic pressure(+dp/dtmax,-dp/dtmax) in model group were signififcantly decreased,with statistically very significant difference (P <0.01).Compared with model group,left end-diastolic pressure(LVEDP) was obviously decreased , left ventricular systolic pressure(LVSP)、cardiac output(CO),as well as maximum rate of rise and fall of left systolic pressure(+dp/dtmax,-dp/dtmax) were signififcantly increased in XFK group and Captopril group,with statistically very significant difference (P <0.01).
(3)The effect of Xinfukang(XFK)oral liquid on the content of energy metabolism material of Heart Failure post Myocardial Infarction in rats Compared with sham group,the contentl of ATP in left ventricular muscle was obviously decreased,but ADP and AMP were significantly increased in model group(p<0.01).Compared with model group ,the content of ATP was obviously increased in XFK oral group and Captopril group,but ADP, AMP were significantly decreased,with statistically very significant diference(P <0.01).
Conclusion:
(1) XFK oral liquid can effectively reduce LVEDP, increase LVSP of Heart Failure post Myocardial Infarction in rats,but has no effect on SBP and DBP,thus to improve hemodynamics steady in rats with heart failure post Myocardial Infarction.
(2) XFK oral liquid can effectively improve -dp/dtmax、+dp/ dtmax,and CO, so as to improve left ventricular systolic and diastolic function in rats of heart failure after myocardial infarction.
(3) XFK oral liquid can effectively improve the content of ATP ,reduce the content of AMP and ADP in left ventricular muscle,thus improve energy metabolism disorder of heart failure after myocardial infarction in rats, in order to protect cardiac function.
方法:采用结扎SD大鼠左冠状动脉前降支致心梗后心衰大鼠模型,大鼠随机分为假手术组(Sham组)、模型组(Model组)、Captopril组(Capt组)、益气活血中药组分为心复康口服液大剂量组(XFK大剂量组)和心复康口服液小剂量组(XFK小剂量组),分别于术后24h灌胃给药,以Captopril作为阳性对照药。给药8周末,观察大鼠血流动力学、心功能及心肌能量代谢物质的的变化。
结果:
(1)XFK对心梗后CHF大鼠血流动力学的影响
与Sham组比较,Model组大鼠舒张压降低,统计学有显著性差异(P<0.05),心率及收缩压变化无统计学意义(P>0.05);与Model组比较,XFK组和Capt组大鼠心率及舒张压变化均无统计学意义,但Capt组大鼠收缩压明显降低,统计学有极显著性差异(P<0.01)。
(2)XFK对心梗后CHF大鼠心功能的影响
与Sham组比较,Model组大鼠左心室舒张末压升高,左心室收缩压、心输出量、左心室内压最大上升速率、左心室内压最大下降速率均显著降低,统计学有极显著性差异(P<0.01);与Model组比较,XFK组和Capt组大鼠左心室舒张末压降低,统计学有显著性差异(P<0.05),左心室收缩压、心输出量、左心室内压最大上升速率、左心室内压最大下降速率均升高,统计学有极显著性差异(P<0.01)。
(3)XFK对CHF大鼠左心室非梗死心肌ATP、AMP、ADP水平的影响
与Sham组比较,Model组大鼠左心室心肌ATP含量降低,ADP、AMP含量明显增高,统计学有极显著性意义(P<0.01);与Model组比较,XFK组和Capt组大鼠左心室心肌ATP水平明显升高,ADP和AMP含量明显降低,统计学有极显著性意义(P<0.01)。
结论:
(1)心复康口服液对心梗后心衰大鼠心率、BSP、BDP无影响,可有效降低心梗后心衰大鼠心脏LVEDP,提高心梗后心衰大鼠LVSP,改善心梗大鼠血液动力学稳态。
(2)心复康口服液可有效提高心梗后心衰大鼠心脏+dp/dtmax、CO,从而改善心梗后心衰大鼠左室收缩和舒张功能。
(3)心复康口服液可有效提高心梗后心衰大鼠心肌能量代谢产物ATP含量,减少AMP、ADP的含量。说明益气活血中药可有效调节心梗后心衰大鼠心肌能量代谢紊乱,改善心梗后心衰大鼠心肌能量代谢重塑,从而保护心功能。
Objetives: To observe the effect of Xinfukang(XFK)oral liquid on hemodynamics、cardiac function and the content of energy metabolism material in the rat model of Heart Failure post Myocardial Infarction.
Methods: The AMI models were established by ligating left anterion descending coronary artery and the rats with AMI were ramdonly divided into Sham group、Model group、Captopril group ,Yiqihuoxue chinese medicine into XFK high dose group and XFK low dose group.Twenty-four hours after establishing models the rats were fed on XFK oral liquid through the gastrotube for 8weeks. Captopril group was serrved as control,After 8 weeks of the treatment,Hemodynamics、cardiac function and the content of energy metabolism material were measured.
Results:
(1) The effect of Xinfukang(XFK)oral liquid on hemodynamics of Heart Failure post Myocardial Infarction in rats Contrast with sham group, diastolic blood pressure in model rats was lowered, with statistically significant difference (P<0.05),heart rate and blood pressure change were not significant (P>0.05);compared with model group, heart rate and diastolic blood pressure changes were not statistically significant both in XFK group and Captopril group,but systolic blood pressure in Captopril group was decreased significantly,with statistically very significant difference (P <0.01)。
(2) the effect of Xinfukang(XFK)oral liquid on cardiac function of Heart Failure post Myocardial Infarction in rats Contrast with sham group,left end-diastolic pressure(LVEDP) was obviously increased , left ventricular systolic pressure(LVSP)、cardiac output(CO),as well as maximum rate of rise and fall of left systolic pressure(+dp/dtmax,-dp/dtmax) in model group were signififcantly decreased,with statistically very significant difference (P <0.01).Compared with model group,left end-diastolic pressure(LVEDP) was obviously decreased , left ventricular systolic pressure(LVSP)、cardiac output(CO),as well as maximum rate of rise and fall of left systolic pressure(+dp/dtmax,-dp/dtmax) were signififcantly increased in XFK group and Captopril group,with statistically very significant difference (P <0.01).
(3)The effect of Xinfukang(XFK)oral liquid on the content of energy metabolism material of Heart Failure post Myocardial Infarction in rats Compared with sham group,the contentl of ATP in left ventricular muscle was obviously decreased,but ADP and AMP were significantly increased in model group(p<0.01).Compared with model group ,the content of ATP was obviously increased in XFK oral group and Captopril group,but ADP, AMP were significantly decreased,with statistically very significant diference(P <0.01).
Conclusion:
(1) XFK oral liquid can effectively reduce LVEDP, increase LVSP of Heart Failure post Myocardial Infarction in rats,but has no effect on SBP and DBP,thus to improve hemodynamics steady in rats with heart failure post Myocardial Infarction.
(2) XFK oral liquid can effectively improve -dp/dtmax、+dp/ dtmax,and CO, so as to improve left ventricular systolic and diastolic function in rats of heart failure after myocardial infarction.
(3) XFK oral liquid can effectively improve the content of ATP ,reduce the content of AMP and ADP in left ventricular muscle,thus improve energy metabolism disorder of heart failure after myocardial infarction in rats, in order to protect cardiac function.
引文
[1] 马 翔 , 张 峰 华 . 保 元 汤 化 裁 治 疗 慢 性 心 力 衰 竭 30 例 . 陕 西 中医,2005,26(7):617-618
[2]李立志.陈可冀治疗充血性心力衰竭经验.中西医结合心脑血管病杂志,2006,4(2):136-138
[3]郑朝炳,马世琼,郑志文.参芪己丹苈蛭龙汤治疗难治性充血性心力衰竭 86 例.中国中西医结合急救杂志,2006,13(6):26
[4] 张万祥,孙元莹,李志军.补阳益心汤治疗难治性心衰 42 例疗效观察.辽宁中医杂志,2006,33(7):836-836
[5] 王振涛.充血性心力衰竭辨治体验,四川中医,2005,23(16):9-10
[6] 张静,张立.中西医结合治疗慢性心力衰竭78例.辽宁中医杂志,2007,34(4):494
[7] 郝永华.辨证治疗慢性充血性心力衰竭 32 例.中国中医急症,2004,13(5):318
[8] 李小平,冯仓怀.中药分期辨证治疗慢性充血性心力衰竭 63 例.陕西中医,2006,27(7):776-777
[9] 黄健,徐秋香,单莉.中西医结合治疗慢性收缩性心力衰竭 42 例,实用中医内科杂志,2007,21(2):33
[10]孙伯青.益气活血法治疗充血性心力衰竭的临床研究.中国中西医结合急救杂志, 2006,13(1):44-45
[11]任美时.益气活血法为主治疗充血性心力衰竭57例分析.2005,23(4):740
[12]穆晓静.中西医结合治疗慢性充血性心力衰竭临床观察.山西中医, 2006,22(2):15
[13]高嵩山,王秀娟.益气滋阴补阳法治疗顽固性心力衰竭 30 例.中医药学刊, 2004,22(3):545
[14]卢宪伟,陈伟平,韦继政.保元汤加味方治疗慢性充血性心力衰竭30例.陕西中医,2006,27(7):772-773
[15]王敏生.温阳强心汤治疗慢性心衰30例.实用中医内科杂志.2005,19(6):557
[16]陈晓峰,沈维增,谢峥伟等.真武汤治疗慢性充血性心力衰竭25例.现代医院,2007,7(8):78
[17]朱晓峰,董德保.真武汤加味治疗慢性充血性心力衰竭57例.陕西中医,2005,26(6):538-539
[18]郑军.温阳利水法治疗慢性心力衰竭 48 例.陕西中医,2005,26(2):103
[19]张丽花.五苓散加减治疗充血性心衰28例疗效观察.中医中药,2006,3(35):107
[20]贺丽娜.防己茯苓汤治疗慢性充血性心力衰竭80例.实用中医内科杂志,2005,19(1):45
[21]张万祥,孙元莹,李志军.补阳益心汤治疗难治性心衰 42 例疗效观察.辽宁中医杂志,2006,33(7):836-836
[22]陈一峰,陈亚兵.生脉散合苓桂术甘汤加味治疗慢性心力衰竭30例.实用中医内科杂志,2005,19(5):454
[23]李金红.中西医结合治疗充血性心力衰竭临床观察.辽宁中医杂志,2006,33(7):860-861
[24]余洪刚,杨国春,王归圣.温阳补心汤配合西药治疗慢性心力衰竭34例.陕西中医,2007,28(2):134-135
[25]张小斌,陈书存.益气温阳活血利水法治疗心力衰竭63例.陕西中医,26(7):614-615
[26]申秋生.血府逐瘀汤合生脉汤并用治疗充血性心力衰竭 36 例.2006,20(1):51
[27]郑朝炳,马世琼,郑志文.参芪己丹苈蛭龙汤治疗难治性充血性心力衰竭86例.中国中西医结合急救杂志, 2006, 13(6):23
[28]耿巍.参附注射液川芎嗪注射液并用治疗充血性心力衰竭30例.实用中医内科杂志, 2005,19(3):271
[29]廖志勇,岳锋,田小园等.参附治疗重症慢性充血性心力衰竭病人的疗效观察.中西医结合心脑血管病杂志,2005, 3(8):729-730
[30]朱俐俐,朱玲玲.参附注射液治疗老年慢性心力衰竭临床研究.华中医学杂志,2006,30(1):52-53
[31]高静.参麦注射液治疗慢性充血性心力衰竭30例.医药论坛杂志,2005,26(3):50-51
[32]谷慧敏.参麦注射液佐治慢性充血性心力衰竭 30 例疗效观察.国医论坛,2006, 21(4):40
[33]郑凤和.中西医结合治疗冠心病心力衰竭疗效观察.浙江中西医结合杂志,2004, 14(4):202-203
[34]李华,王振涛,黄斌.心衰康颗粒对心肌梗死后心力衰竭患者血清MMP-2及TIMP-2水平的影响.国医论坛,2006, 21(1):30
[35]张晓江,李庆,李旭等.心衰灵冲剂治疗充血性心力衰竭临床研究.国医论坛, 2006,21(1):30
[36]梁晨.益心通脉片倍他乐克并用治疗慢性充血性心力衰竭52例.实用中医内科杂志,2007,21(1):79
[37]杨锋,程晓威,张宇雷.麝香保心丸在慢性心力衰竭中的治疗价值.中原医刊,2007,34(7):80
[38]邹旭,刘泽银,潘光明等.暖心胶囊治疗慢性充血性心力衰竭的远期疗效观察.上海中医药杂志,2006,40(2):69-71
[39]周金荣.补气养心胶囊治疗慢性心功能不全136例.陕西中医,2005,26(11):1136-1137
[40]王玉英,霍燕.中西医结合治疗慢性心力衰竭疗效观察.山西中医,2006,22(1):27
[41]刘绍峰,刘晓静,李秋莉等.中西医结合治疗慢性充血性心力衰竭36例观察.实用中医药杂志,2005,21(4):24
[42]胡耀俊,张军科,荣军海.中西医结合治疗慢性充血性心力衰竭 32 例.现代中医药,2005,25(5):5-6
[43]邰学锋.中西医结合治疗充血性心力衰竭32例总结.湖南中医杂志,2005,21(5):18-19
[44]王兆为.中西医结合治疗充血性心力衰竭61例临床观察.医学理论与实践,2007 20(3):283-283
[45]方晓江,钱宝庆.益气健脾利水法对慢性收缩性心力衰竭患者血浆脑利钠多肽水平的影响.现代中西医结合杂志,2007,16(11):1481-1482
[46]蒋再轶.中西医结合治疗难治性心力衰竭34例临床观察.中医药导报,2006,12(7):32
[47]康珺楠.中西医结合治疗肺心病顽固性心力衰竭21例.甘肃中医,2007,20(6):15
[48]周惠卿,谢滨,陈艳华等.黄芪合血塞通注射液治疗顽固性心力衰竭 32 例.陕西中医,2005,26(11):1138
[49]王辉,李兰芳.步长稳心颗粒对慢性心力衰竭心率的影响.中国实用中医,2007,2(23):45-46
[50]杨玉梅,覃建民,徐辉等.抗心力衰竭号口服液对实验性充血性心力衰竭的影响.中草药,2003,34(7):642-644
[52]苏玉新,朱冬霞.保心抗衰汤治疗慢性充血性心力衰竭 41 例.陕西中医,2006, 2 (27):132-133.
[53]姜丹.杨积武教授中医药治疗慢性心力衰竭经验集要.中医药学刊, 2005,3(23):13
[54]沈映君,主编中药药理学.上海科技出版社.2003:164
[55]陈金水,吴天敏,王华军.复方黄精口服液对鼠心肌细胞自由基代谢及血清心肌酶的影响.中西医结合心脑血管病杂志,2003,1(3):134-136
[56]张艳丽.葛根素注射液对充血性心力衰竭患者血浆内皮素水平的影响.中国中西医结合急救杂志,2003,10(4):234-235
[57]李荣堂,胡建福.复方丹参滴丸对冠心病合并充血性心力衰竭患者CGRP和ET浓度的影响.中国老年学杂志,2003,23:424-425
[58]王敬民,金炜.参麦注射液对心力衰竭患者ET及TNF-a的影响.浙江中西医结合杂志,2004,14(1):4-5
[59]马路,刘剑刚,陈可冀等.参芪扶心口服液对心力衰竭大鼠血浆利钾尿肽、左室舒缩性能及左室重塑的影响.中国中药杂志,2003,7(28):656-660
[60]陈宇鹏,黄衍寿.保心康对家兔实验性心功不全动物模型的药效学研究.广州中医药大学,2002,1(19):36-42
[61]方国璋,王红星,尹华虎等.心元胶囊抗心衰作用的实验研究.中国中医急症,2002,3(11):208
[62]龙新生,吕萍,莫劲松等.加味真武汤对充血性心力衰竭少阴病阳虚水停证兔血流动力学的影响.中国中医药信息杂志,2004,6(11):489-491
[63]韩红亚,李瑞.仙人强心片对充血性心力衰竭家兔氧自由基清除作用的实验研究.山西中医学院学报,2004,5(1):19-20
[64]陈兆善,董耀荣,胡婉英.强心合剂对慢性心力衰竭大鼠心肌细胞凋亡的影响.中西医结合心脑血管病杂志,2003,1(9):518-520
[65]王振涛.充血性心力衰竭辨治体验.四川中医,2005,23(16):9-10
[66]陈金星,王硕仁,赵明镜等.活血益气药不同剂量配伍对心梗后心衰大鼠心脏系数及功能的影响.中国中药杂志,2003,5(28):446-449
[67]林亚洲,许春萱,黄海等.川芎嗪干预心力衰竭实验犬心房组织IIV型胶原与TGF-B1 的 mRNA 表 达 研 究 .ChieseJournal of integrative medicineon cardio-cerebro vascular disease,2005,6(3):512-514
[68]徐俊波,吴时达,王静等。温阳健心灵对心肾阳虚型心衰大鼠影响的实验研究.中医药学刊,2003,9(23):1419-1420
[69]李金祥,方居正.温阳益气汤对慢性心功能不全患者血清B型钠尿肽的影响.湖北中医杂志,2006,28(3):31
[70]夏纪筑,罗兴林.心肌能量学研究进展.医学综述.2004,10(6):341-343
[71]夏冰.缺血性心肌病药物治疗的能量代谢支持作用.西北国防医学杂志,2005,26(6):443
[72]LiuB,Alaoui-TalibiZ,Clanachan AS,et al.Uncoupling of contractile function from mitochond rialtricarboxylic acid cycle activity and oxygen consumption during reper fusion of ischemic rat hearts [J].Am JPhysiol,1996,270(1):H72-H80
[73]Lopaschuk GD.Alterations in fatty acid oxidation during reperfusion of the heart after myocardia lischemia[J].Am JCardiol,1997,80(3):11A-16A
[74]庄海舟.慢性心力衰竭与心肌能量代谢.心血管病学进展,2004,25(6):466
[75]Yu GS , Lu YC , Gulick T.Co-regulation of tissue specific alterative human carnitine palmitoyltransferase1 gene promoters by fatty acid enzyme substrate.J Biol Chem , 1998 , 273 :32 901 - 909
[76]Watanabe K, Fujii H , Takahashi T, Kodama M , Aizawa Y, Ohta Y, et al.Constitutive regulation of cardiac fatty acid metabolism through peroxisome prolifer ator-activated receptorαassociated with age-dependent cardiac toxicity.J Biol Chem , 2000 , 275 :22 293 - 299
[77]叶平.过氧化体增殖物激活型受体对心肌能量代谢调控的病理生理机制.中国动脉硬化杂志.2003,11(1):81
[78]王红梅,刘亚华,张建龙等. 鼠肝缺血/再灌注损伤时心肌组织能量代谢的变化. 新疆医科大学学报,2005,28(4):450
[79]高嵩玲,李欢民,单继平.保护心肌能量代谢与抗心衰治疗的关系探讨.济宁医学院学报,1998,21(4)
[80]任江华,姜黎,曹茂银. 丙酮酸对顿抑心肌功能及能量代谢的作用.中国老年学杂志,2004,8(24):720
[81]ClonghD,BungerR.Protection by pyruvate against inhibition of Na+,K+-ATPase by a free radical generating system containing t-butylhydroper onide[J].LifeSci,1995;57:931-943
[82]Crestanello JA,Kamelgard J, Whitman GJR,et al.The cumulativ nature of pyruvate's dual mechanism for myocardial protection [J].Surg Res,1995;59:198-204
[83]Mallet RT,Bunger R.Eenegetic modulation of cardiac inotropism and sarcoplasmic reticular Ca2+ uptake[J].Biochim Biophys Acta,1994,1224:22-32
[84]殷仁富,陈金明。心脏能量学[M].第二军医大学出版社,2002,19
[85]宋熔、祝善俊、聂凌等.卡维地洛改善大鼠肥厚心肌能量代谢及其机制.心脏杂志.2007,19(4):402
[86]袁 王景,廖玉华,汪朝晖,等.腺苷酸转位酶诱导自身免疫性心肌病小鼠的异常T 细胞受体信号通路[J].中国病理生理杂志,2006,22: .
[87]张子彬,Tsung O.Cheng[美],张玉传.充血性心力衰竭学[M].北京:科学技术文献出版社,2000.
[88]Xin HB,Zhang BH,Liu,et al.Protective effects of cyproheptadine on isoprenaline induce dmy cardiardial injury inratinvivo [J].Chinese Journal of pharmacology and toxicology,1993,7(3):176.
[89]NEUBAUER S.High-energy phosphate metabolism in normal hypertrophied and failing human myocardium [J].Heart Failure Rev,1999,4:269-280
[90]殷惠军,蒋跃绒,刘颖等.参桂胶囊对心肌细胞能量代谢及脂质过氧化影响的研究.中医药信息,2004,21(3):71
[91]祝善俊,宋跃明,李隆贵,等.心力衰竭时心肌能量代谢的初步研究[J].中华心血管病杂志,1995,23(2):104-106.
[92]邱宏,金国琴,张学礼等.调心方对氧化损伤型类 AD 大鼠能量代谢的影响.中药药理与临床.2002,18(1):18-20
[93]曹雪滨,朱永成,王朝宏等.心复康对去甲肾上腺素性心肌损伤超微结构及膜通透性改变的影响.河北中医.1996,17(3):20
[94]何建成,王朝宏. 心复康口服液对兔去甲肾上腺素性心肌病超微结构的影响.甘肃中医学院学报,1995,(2):44
[95] 何建成,王朝宏. 心复康口服液对兔去甲肾上腺素性心肌病影响的研究.中国实用中西医结合杂志,1995,(12):755
[96]何建成,王朝宏,曹雪滨.心复康口服液对兔去甲肾上腺素性心肌病 Cu2+、Zn2+影响的研究.甘肃中医,1995,8(5):11
[97] 曹雪滨,何建成,胡元会.气虚血瘀型心力衰竭患者血液流变学改变及心复康口服液对其影响.浙江中医杂志,待发表.
[98]曹雪滨,王朝宏,朱永成等.中西医结合治疗扩张型心肌病心力衰竭 21 例疗效观察.国医论坛,1995,(1);36
[99]何建成.老年冠心病中医药的再思考.中医研究,1999,12(2):5
[100]徐义枢、高润霖,等.急性心肌梗死并低血压和休克的临床及血流动力学.中华心血管临床杂志.1986,14:88
[101]Pfeffer.JM, Pfeffer MA.Braunwald E,et al.Influence of chronic captopril therapy on the infarcted left ventricle of the rat.Cir,Res 1985.57:84-95
[102]Litwin SE.katz SE.Morgan JP,et al.Long term captopril treatment improves diastolic filling more than systolic performance in rats with large myocardial infarction. J Am Coll Cardial 1996.28:773-781
[103]Pfeffer JM,Pfeffer,Braunwald E,et al.Hemodynamic benefits and prolonged survival with long-term captopril therapy in rats with myocardial infarction and heart failure circulation. 1978.75(suppl I):149-155
[104]林海龙,雷立权,卢兴.长期应用巯甲丙脯酸对心肌梗塞大鼠心脏构筑与左室功能的影响.中国病理生理杂志,1993,9(1):20
[105]Judutt MA,Schwarz-Michorowski BL,Khan MI,et al.Effect of long-term captopril therapy on left ventricular remoding and function during healing of canine MI.J Am.Coll Cardiol 1992,19:713-721
[106]Milvetz JJ,Roya TE,Johnson CS.et al.Survival after myocardial infarction in rats.Captopril versus losartan.J Am.Coll Cardiol 1996,27:714-719
[107]中国心脏研究(暨 EI-AMI 研究)协作组.中国心脏研究:卡托普利对急性心肌梗塞患者早期病死率和并发症影响的各种临床试验-全国大规模随机双盲安慰剂对照临床实验 14962 例资料总结.中华心血管病杂志,1997.25(4),245-249
[108]王小庆、彭长农、虞准、等.大鼠急性心肌梗死后心功能变化及病理演变的实验研究.罕见疾病杂志,2007,14(1):1-4
[109]张沛,杨跃进,宋来凤,等.大、中、小剂量依那普利防治大鼠急性心肌梗塞左心室重构的作用对比.中国循环杂志.2001,16(4):255-258
[110]Judgutt BI , Kham MI.Judgutt SJ.et al.Effect of enalaprilon on rentricular remodeling and function during healing after anterior myocardial infarction in the dog.Circulation.1994,91:802-812
[111]Litwin.SE,katz SE,Morgan TP, et al.long term captopril treatment improves diastolic falling more than systalic performance in rats with large myocardial infarction.J Am.coll.Cardial,1996,28,733-781
[112]胡元会、曹雪滨、曹贵民,等. 心复康口服液对实验心衰模型大鼠心肌细胞自由基代谢和膜通透性的影响.中国中医基础医学杂志,2000,2(6):16-19
[113]董国菊,刘剑刚,史大卓等.愈心梗液对急性心肌梗死大鼠心肌能量代谢和内皮功能障碍的影响.中国中医急症.2005,9(14):872-873
[2]李立志.陈可冀治疗充血性心力衰竭经验.中西医结合心脑血管病杂志,2006,4(2):136-138
[3]郑朝炳,马世琼,郑志文.参芪己丹苈蛭龙汤治疗难治性充血性心力衰竭 86 例.中国中西医结合急救杂志,2006,13(6):26
[4] 张万祥,孙元莹,李志军.补阳益心汤治疗难治性心衰 42 例疗效观察.辽宁中医杂志,2006,33(7):836-836
[5] 王振涛.充血性心力衰竭辨治体验,四川中医,2005,23(16):9-10
[6] 张静,张立.中西医结合治疗慢性心力衰竭78例.辽宁中医杂志,2007,34(4):494
[7] 郝永华.辨证治疗慢性充血性心力衰竭 32 例.中国中医急症,2004,13(5):318
[8] 李小平,冯仓怀.中药分期辨证治疗慢性充血性心力衰竭 63 例.陕西中医,2006,27(7):776-777
[9] 黄健,徐秋香,单莉.中西医结合治疗慢性收缩性心力衰竭 42 例,实用中医内科杂志,2007,21(2):33
[10]孙伯青.益气活血法治疗充血性心力衰竭的临床研究.中国中西医结合急救杂志, 2006,13(1):44-45
[11]任美时.益气活血法为主治疗充血性心力衰竭57例分析.2005,23(4):740
[12]穆晓静.中西医结合治疗慢性充血性心力衰竭临床观察.山西中医, 2006,22(2):15
[13]高嵩山,王秀娟.益气滋阴补阳法治疗顽固性心力衰竭 30 例.中医药学刊, 2004,22(3):545
[14]卢宪伟,陈伟平,韦继政.保元汤加味方治疗慢性充血性心力衰竭30例.陕西中医,2006,27(7):772-773
[15]王敏生.温阳强心汤治疗慢性心衰30例.实用中医内科杂志.2005,19(6):557
[16]陈晓峰,沈维增,谢峥伟等.真武汤治疗慢性充血性心力衰竭25例.现代医院,2007,7(8):78
[17]朱晓峰,董德保.真武汤加味治疗慢性充血性心力衰竭57例.陕西中医,2005,26(6):538-539
[18]郑军.温阳利水法治疗慢性心力衰竭 48 例.陕西中医,2005,26(2):103
[19]张丽花.五苓散加减治疗充血性心衰28例疗效观察.中医中药,2006,3(35):107
[20]贺丽娜.防己茯苓汤治疗慢性充血性心力衰竭80例.实用中医内科杂志,2005,19(1):45
[21]张万祥,孙元莹,李志军.补阳益心汤治疗难治性心衰 42 例疗效观察.辽宁中医杂志,2006,33(7):836-836
[22]陈一峰,陈亚兵.生脉散合苓桂术甘汤加味治疗慢性心力衰竭30例.实用中医内科杂志,2005,19(5):454
[23]李金红.中西医结合治疗充血性心力衰竭临床观察.辽宁中医杂志,2006,33(7):860-861
[24]余洪刚,杨国春,王归圣.温阳补心汤配合西药治疗慢性心力衰竭34例.陕西中医,2007,28(2):134-135
[25]张小斌,陈书存.益气温阳活血利水法治疗心力衰竭63例.陕西中医,26(7):614-615
[26]申秋生.血府逐瘀汤合生脉汤并用治疗充血性心力衰竭 36 例.2006,20(1):51
[27]郑朝炳,马世琼,郑志文.参芪己丹苈蛭龙汤治疗难治性充血性心力衰竭86例.中国中西医结合急救杂志, 2006, 13(6):23
[28]耿巍.参附注射液川芎嗪注射液并用治疗充血性心力衰竭30例.实用中医内科杂志, 2005,19(3):271
[29]廖志勇,岳锋,田小园等.参附治疗重症慢性充血性心力衰竭病人的疗效观察.中西医结合心脑血管病杂志,2005, 3(8):729-730
[30]朱俐俐,朱玲玲.参附注射液治疗老年慢性心力衰竭临床研究.华中医学杂志,2006,30(1):52-53
[31]高静.参麦注射液治疗慢性充血性心力衰竭30例.医药论坛杂志,2005,26(3):50-51
[32]谷慧敏.参麦注射液佐治慢性充血性心力衰竭 30 例疗效观察.国医论坛,2006, 21(4):40
[33]郑凤和.中西医结合治疗冠心病心力衰竭疗效观察.浙江中西医结合杂志,2004, 14(4):202-203
[34]李华,王振涛,黄斌.心衰康颗粒对心肌梗死后心力衰竭患者血清MMP-2及TIMP-2水平的影响.国医论坛,2006, 21(1):30
[35]张晓江,李庆,李旭等.心衰灵冲剂治疗充血性心力衰竭临床研究.国医论坛, 2006,21(1):30
[36]梁晨.益心通脉片倍他乐克并用治疗慢性充血性心力衰竭52例.实用中医内科杂志,2007,21(1):79
[37]杨锋,程晓威,张宇雷.麝香保心丸在慢性心力衰竭中的治疗价值.中原医刊,2007,34(7):80
[38]邹旭,刘泽银,潘光明等.暖心胶囊治疗慢性充血性心力衰竭的远期疗效观察.上海中医药杂志,2006,40(2):69-71
[39]周金荣.补气养心胶囊治疗慢性心功能不全136例.陕西中医,2005,26(11):1136-1137
[40]王玉英,霍燕.中西医结合治疗慢性心力衰竭疗效观察.山西中医,2006,22(1):27
[41]刘绍峰,刘晓静,李秋莉等.中西医结合治疗慢性充血性心力衰竭36例观察.实用中医药杂志,2005,21(4):24
[42]胡耀俊,张军科,荣军海.中西医结合治疗慢性充血性心力衰竭 32 例.现代中医药,2005,25(5):5-6
[43]邰学锋.中西医结合治疗充血性心力衰竭32例总结.湖南中医杂志,2005,21(5):18-19
[44]王兆为.中西医结合治疗充血性心力衰竭61例临床观察.医学理论与实践,2007 20(3):283-283
[45]方晓江,钱宝庆.益气健脾利水法对慢性收缩性心力衰竭患者血浆脑利钠多肽水平的影响.现代中西医结合杂志,2007,16(11):1481-1482
[46]蒋再轶.中西医结合治疗难治性心力衰竭34例临床观察.中医药导报,2006,12(7):32
[47]康珺楠.中西医结合治疗肺心病顽固性心力衰竭21例.甘肃中医,2007,20(6):15
[48]周惠卿,谢滨,陈艳华等.黄芪合血塞通注射液治疗顽固性心力衰竭 32 例.陕西中医,2005,26(11):1138
[49]王辉,李兰芳.步长稳心颗粒对慢性心力衰竭心率的影响.中国实用中医,2007,2(23):45-46
[50]杨玉梅,覃建民,徐辉等.抗心力衰竭号口服液对实验性充血性心力衰竭的影响.中草药,2003,34(7):642-644
[52]苏玉新,朱冬霞.保心抗衰汤治疗慢性充血性心力衰竭 41 例.陕西中医,2006, 2 (27):132-133.
[53]姜丹.杨积武教授中医药治疗慢性心力衰竭经验集要.中医药学刊, 2005,3(23):13
[54]沈映君,主编中药药理学.上海科技出版社.2003:164
[55]陈金水,吴天敏,王华军.复方黄精口服液对鼠心肌细胞自由基代谢及血清心肌酶的影响.中西医结合心脑血管病杂志,2003,1(3):134-136
[56]张艳丽.葛根素注射液对充血性心力衰竭患者血浆内皮素水平的影响.中国中西医结合急救杂志,2003,10(4):234-235
[57]李荣堂,胡建福.复方丹参滴丸对冠心病合并充血性心力衰竭患者CGRP和ET浓度的影响.中国老年学杂志,2003,23:424-425
[58]王敬民,金炜.参麦注射液对心力衰竭患者ET及TNF-a的影响.浙江中西医结合杂志,2004,14(1):4-5
[59]马路,刘剑刚,陈可冀等.参芪扶心口服液对心力衰竭大鼠血浆利钾尿肽、左室舒缩性能及左室重塑的影响.中国中药杂志,2003,7(28):656-660
[60]陈宇鹏,黄衍寿.保心康对家兔实验性心功不全动物模型的药效学研究.广州中医药大学,2002,1(19):36-42
[61]方国璋,王红星,尹华虎等.心元胶囊抗心衰作用的实验研究.中国中医急症,2002,3(11):208
[62]龙新生,吕萍,莫劲松等.加味真武汤对充血性心力衰竭少阴病阳虚水停证兔血流动力学的影响.中国中医药信息杂志,2004,6(11):489-491
[63]韩红亚,李瑞.仙人强心片对充血性心力衰竭家兔氧自由基清除作用的实验研究.山西中医学院学报,2004,5(1):19-20
[64]陈兆善,董耀荣,胡婉英.强心合剂对慢性心力衰竭大鼠心肌细胞凋亡的影响.中西医结合心脑血管病杂志,2003,1(9):518-520
[65]王振涛.充血性心力衰竭辨治体验.四川中医,2005,23(16):9-10
[66]陈金星,王硕仁,赵明镜等.活血益气药不同剂量配伍对心梗后心衰大鼠心脏系数及功能的影响.中国中药杂志,2003,5(28):446-449
[67]林亚洲,许春萱,黄海等.川芎嗪干预心力衰竭实验犬心房组织IIV型胶原与TGF-B1 的 mRNA 表 达 研 究 .ChieseJournal of integrative medicineon cardio-cerebro vascular disease,2005,6(3):512-514
[68]徐俊波,吴时达,王静等。温阳健心灵对心肾阳虚型心衰大鼠影响的实验研究.中医药学刊,2003,9(23):1419-1420
[69]李金祥,方居正.温阳益气汤对慢性心功能不全患者血清B型钠尿肽的影响.湖北中医杂志,2006,28(3):31
[70]夏纪筑,罗兴林.心肌能量学研究进展.医学综述.2004,10(6):341-343
[71]夏冰.缺血性心肌病药物治疗的能量代谢支持作用.西北国防医学杂志,2005,26(6):443
[72]LiuB,Alaoui-TalibiZ,Clanachan AS,et al.Uncoupling of contractile function from mitochond rialtricarboxylic acid cycle activity and oxygen consumption during reper fusion of ischemic rat hearts [J].Am JPhysiol,1996,270(1):H72-H80
[73]Lopaschuk GD.Alterations in fatty acid oxidation during reperfusion of the heart after myocardia lischemia[J].Am JCardiol,1997,80(3):11A-16A
[74]庄海舟.慢性心力衰竭与心肌能量代谢.心血管病学进展,2004,25(6):466
[75]Yu GS , Lu YC , Gulick T.Co-regulation of tissue specific alterative human carnitine palmitoyltransferase1 gene promoters by fatty acid enzyme substrate.J Biol Chem , 1998 , 273 :32 901 - 909
[76]Watanabe K, Fujii H , Takahashi T, Kodama M , Aizawa Y, Ohta Y, et al.Constitutive regulation of cardiac fatty acid metabolism through peroxisome prolifer ator-activated receptorαassociated with age-dependent cardiac toxicity.J Biol Chem , 2000 , 275 :22 293 - 299
[77]叶平.过氧化体增殖物激活型受体对心肌能量代谢调控的病理生理机制.中国动脉硬化杂志.2003,11(1):81
[78]王红梅,刘亚华,张建龙等. 鼠肝缺血/再灌注损伤时心肌组织能量代谢的变化. 新疆医科大学学报,2005,28(4):450
[79]高嵩玲,李欢民,单继平.保护心肌能量代谢与抗心衰治疗的关系探讨.济宁医学院学报,1998,21(4)
[80]任江华,姜黎,曹茂银. 丙酮酸对顿抑心肌功能及能量代谢的作用.中国老年学杂志,2004,8(24):720
[81]ClonghD,BungerR.Protection by pyruvate against inhibition of Na+,K+-ATPase by a free radical generating system containing t-butylhydroper onide[J].LifeSci,1995;57:931-943
[82]Crestanello JA,Kamelgard J, Whitman GJR,et al.The cumulativ nature of pyruvate's dual mechanism for myocardial protection [J].Surg Res,1995;59:198-204
[83]Mallet RT,Bunger R.Eenegetic modulation of cardiac inotropism and sarcoplasmic reticular Ca2+ uptake[J].Biochim Biophys Acta,1994,1224:22-32
[84]殷仁富,陈金明。心脏能量学[M].第二军医大学出版社,2002,19
[85]宋熔、祝善俊、聂凌等.卡维地洛改善大鼠肥厚心肌能量代谢及其机制.心脏杂志.2007,19(4):402
[86]袁 王景,廖玉华,汪朝晖,等.腺苷酸转位酶诱导自身免疫性心肌病小鼠的异常T 细胞受体信号通路[J].中国病理生理杂志,2006,22: .
[87]张子彬,Tsung O.Cheng[美],张玉传.充血性心力衰竭学[M].北京:科学技术文献出版社,2000.
[88]Xin HB,Zhang BH,Liu,et al.Protective effects of cyproheptadine on isoprenaline induce dmy cardiardial injury inratinvivo [J].Chinese Journal of pharmacology and toxicology,1993,7(3):176.
[89]NEUBAUER S.High-energy phosphate metabolism in normal hypertrophied and failing human myocardium [J].Heart Failure Rev,1999,4:269-280
[90]殷惠军,蒋跃绒,刘颖等.参桂胶囊对心肌细胞能量代谢及脂质过氧化影响的研究.中医药信息,2004,21(3):71
[91]祝善俊,宋跃明,李隆贵,等.心力衰竭时心肌能量代谢的初步研究[J].中华心血管病杂志,1995,23(2):104-106.
[92]邱宏,金国琴,张学礼等.调心方对氧化损伤型类 AD 大鼠能量代谢的影响.中药药理与临床.2002,18(1):18-20
[93]曹雪滨,朱永成,王朝宏等.心复康对去甲肾上腺素性心肌损伤超微结构及膜通透性改变的影响.河北中医.1996,17(3):20
[94]何建成,王朝宏. 心复康口服液对兔去甲肾上腺素性心肌病超微结构的影响.甘肃中医学院学报,1995,(2):44
[95] 何建成,王朝宏. 心复康口服液对兔去甲肾上腺素性心肌病影响的研究.中国实用中西医结合杂志,1995,(12):755
[96]何建成,王朝宏,曹雪滨.心复康口服液对兔去甲肾上腺素性心肌病 Cu2+、Zn2+影响的研究.甘肃中医,1995,8(5):11
[97] 曹雪滨,何建成,胡元会.气虚血瘀型心力衰竭患者血液流变学改变及心复康口服液对其影响.浙江中医杂志,待发表.
[98]曹雪滨,王朝宏,朱永成等.中西医结合治疗扩张型心肌病心力衰竭 21 例疗效观察.国医论坛,1995,(1);36
[99]何建成.老年冠心病中医药的再思考.中医研究,1999,12(2):5
[100]徐义枢、高润霖,等.急性心肌梗死并低血压和休克的临床及血流动力学.中华心血管临床杂志.1986,14:88
[101]Pfeffer.JM, Pfeffer MA.Braunwald E,et al.Influence of chronic captopril therapy on the infarcted left ventricle of the rat.Cir,Res 1985.57:84-95
[102]Litwin SE.katz SE.Morgan JP,et al.Long term captopril treatment improves diastolic filling more than systolic performance in rats with large myocardial infarction. J Am Coll Cardial 1996.28:773-781
[103]Pfeffer JM,Pfeffer,Braunwald E,et al.Hemodynamic benefits and prolonged survival with long-term captopril therapy in rats with myocardial infarction and heart failure circulation. 1978.75(suppl I):149-155
[104]林海龙,雷立权,卢兴.长期应用巯甲丙脯酸对心肌梗塞大鼠心脏构筑与左室功能的影响.中国病理生理杂志,1993,9(1):20
[105]Judutt MA,Schwarz-Michorowski BL,Khan MI,et al.Effect of long-term captopril therapy on left ventricular remoding and function during healing of canine MI.J Am.Coll Cardiol 1992,19:713-721
[106]Milvetz JJ,Roya TE,Johnson CS.et al.Survival after myocardial infarction in rats.Captopril versus losartan.J Am.Coll Cardiol 1996,27:714-719
[107]中国心脏研究(暨 EI-AMI 研究)协作组.中国心脏研究:卡托普利对急性心肌梗塞患者早期病死率和并发症影响的各种临床试验-全国大规模随机双盲安慰剂对照临床实验 14962 例资料总结.中华心血管病杂志,1997.25(4),245-249
[108]王小庆、彭长农、虞准、等.大鼠急性心肌梗死后心功能变化及病理演变的实验研究.罕见疾病杂志,2007,14(1):1-4
[109]张沛,杨跃进,宋来凤,等.大、中、小剂量依那普利防治大鼠急性心肌梗塞左心室重构的作用对比.中国循环杂志.2001,16(4):255-258
[110]Judgutt BI , Kham MI.Judgutt SJ.et al.Effect of enalaprilon on rentricular remodeling and function during healing after anterior myocardial infarction in the dog.Circulation.1994,91:802-812
[111]Litwin.SE,katz SE,Morgan TP, et al.long term captopril treatment improves diastolic falling more than systalic performance in rats with large myocardial infarction.J Am.coll.Cardial,1996,28,733-781
[112]胡元会、曹雪滨、曹贵民,等. 心复康口服液对实验心衰模型大鼠心肌细胞自由基代谢和膜通透性的影响.中国中医基础医学杂志,2000,2(6):16-19
[113]董国菊,刘剑刚,史大卓等.愈心梗液对急性心肌梗死大鼠心肌能量代谢和内皮功能障碍的影响.中国中医急症.2005,9(14):872-873